We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.62%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.4B
AUM Growth
+$6.86B
(+9.1%)
Cap. Flow
+$638M
Cap. Flow
% of AUM
0.77%
Top 10 Holdings %
Top 10 Hldgs %
14.3%
Holding
1,037
New
122
Increased
448
Reduced
276
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$390M |
| 2 |
Ambev
ABEV
|
+$272M |
| 3 |
GE Aerospace
GE
|
+$244M |
| 4 |
Intuitive Surgical
ISRG
|
+$208M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$433M |
| 2 |
Microsoft
MSFT
|
+$293M |
| 3 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$284M |
| 4 |
Qualcomm
QCOM
|
+$272M |
| 5 |
United Parcel Service
UPS
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.23% |
| 2 | Financials | 14.08% |
| 3 | Communication Services | 12.37% |
| 4 | Healthcare | 11.68% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Avnet
AVT
$7.33B
| $102M | 0.12% |
2,314,219
+1,178,385
| +104% | +$48.6M |
|
202
American Express
AXP
$223B
| $102M | 0.12% |
1,119,826
-80,220
| -7% | -$6.59M |
|
203
Texas Instruments
TXN
$255B
| $100M | 0.12% |
2,278,458
| – | – |
|
204
O'Reilly Automotive
ORLY
$72.4B
| $99.8M | 0.12% |
11,627,460
-6,866,700
| -37% | -$57.9M |
|
205
Lear
LEA
$7.19B
| $99.3M | 0.12% |
1,226,350
+100
| +0% | +$7.83K |
|
|
TOO
206
DELISTED
Teekay Offshore Partners L.P.
TOO
| $99.3M | 0.12% |
3,195,570
+862,030
| +37% | +$28.2M |
|
|
VIAB
207
DELISTED
Viacom Inc. Class B
VIAB
| $96.9M | 0.12% |
1,109,518
+992,478
| +848% | +$82M |
|
208
Corning
GLW
$126B
| $95.5M | 0.12% |
5,358,718
-2,333,772
| -30% | -$38.4M |
|
209
Johnson & Johnson
JNJ
$635B
| $95.1M | 0.12% |
1,038,497
-418,470
| -29% | -$38.6M |
|
210
Guidewire Software
GWRE
$11.5B
| $94.8M | 0.12% |
1,932,713
+96,417
| +5% | +$4.55M |
|
|
SDLP
211
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $94.8M | 0.12% |
305,918
+248,237
| +430% | +$79.5M |
|
212
Delta Air Lines
DAL
$55.9B
| $93.8M | 0.11% |
3,415,435
-319,150
| -9% | -$8.58M |
|
213
Becton Dickinson
BDX
$43.1B
| $92.9M | 0.11% |
862,056
-161,396
| -16% | -$16.7M |
|
214
IMAX
IMAX
$2.38B
| $91.6M | 0.11% |
3,106,684
-1,088,131
| -26% | -$31.3M |
|
215
Assured Guaranty
AGO
$3.78B
| $91.4M | 0.11% |
3,873,551
+274,803
| +8% | +$5.98M |
|
216
Celldex Therapeutics
CLDX
$2.77B
| $91M | 0.11% |
250,715
+234,121
| +1,411% | +$90.2M |
|
217
Lumen
LUMN
$6.53B
| $89.2M | 0.11% |
2,800,990
-265
| -0% | -$8.47K |
|
|
KRFT
218
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $89.2M | 0.11% |
1,654,311
-2,800,747
| -63% | -$150M |
|
|
OCR
219
DELISTED
OMNICARE INC
OCR
| $88M | 0.11% |
1,458,265
-8,110
| -0.6% | -$464K |
|
|
MDVN
220
DELISTED
MEDIVATION, INC.
MDVN
| $87.3M | 0.11% |
2,734,624
-50,938
| -2% | -$1.54M |
|
|
WBA
221
DELISTED
Walgreens Boots Alliance
WBA
| $87.3M | 0.11% |
1,519,022
-188,330
| -11% | -$11M |
|
222
TripAdvisor
TRIP
$1.59B
| $87.2M | 0.11% |
1,052,410
-61,640
| -6% | -$5.04M |
|
223
Oneok
OKE
$58.7B
| $87.2M | 0.11% |
1,601,118
+103,915
| +7% | +$5.21M |
|
224
CoStar Group
CSGP
$11.3B
| $84.3M | 0.1% |
4,569,600
+387,400
| +9% | +$6.85M |
|
225
A.O. Smith
AOS
$8.38B
| $83.5M | 0.1% |
3,097,660
+127,620
| +4% | +$3.27M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2013 Portfolio in Review
As of Q4 2013, OppenheimerFunds held 1,037 positions worth $82.4B, up 9.1% from $75.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q4 2013 filing shows 122 new, 448 increased, 276 reduced and 133 closed positions. Its largest new stake was Ambev: 37,192,110 shares worth $273M. The largest sale was IBM, an estimated $433M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 17% a quarter earlier, followed by Financials and Communication Services.
- OppenheimerFunds's largest Q4 2013 buy was Ambev: 37,192,110 shares worth $273M.
- OppenheimerFunds added most to Allergan plc in Q4 2013, an estimated $390M increase.
- OppenheimerFunds's biggest Q4 2013 reduction was Microsoft, cutting an estimated $293M.
- OppenheimerFunds fully exited IBM in Q4 2013, selling an estimated $433M.
- OppenheimerFunds's ten largest holdings make up 14% of its $82.4B portfolio in Q4 2013.
- OppenheimerFunds opened 122 new positions and closed 133 in Q4 2013.
- OppenheimerFunds's portfolio value rose 9.1% quarter-over-quarter to $82.4B.
Based on OppenheimerFunds's 13F filing for Q4 2013, filed 12 Feb 2014.